2024
|
Invention
|
Compounds and compositions as smarca2/4 degraders and uses thereof. Described herein are compound... |
|
Invention
|
Compounds and compositions as cbp/p300 degraders and uses thereof.
Described herein are compound... |
|
Invention
|
Compounds and compositions as cbp/p300 degraders and uses thereof. Described herein are compounds... |
|
Invention
|
Methods of identifying compounds for inducing protein-protein interaction. The present disclosure... |
|
Invention
|
Compounds and compositions as cereblon ligands and uses thereof. e.g.,e.g., as cereblon-binding a... |
|
Invention
|
Compounds and compositions as cbp/p300 degraders and uses thereof. e.g.,e.g., for degrading certa... |
|
Invention
|
Compounds and compositions as stat3 degraders and uses thereof. Described herein are compounds of... |
2023
|
Invention
|
Cereblon ligands and uses thereof. e.g.,e.g., as cereblon-binding agents or bifunctional degrader... |
|
Invention
|
Cereblon ligands and uses thereof. Described herein are compounds of Formula II or conjugates of ... |
|
Invention
|
Compounds and compositions as smarca2/4 inhibitors and uses thereof. Described herein are compoun... |
|
Invention
|
Cereblon ligands and uses thereof.
Described herein are compounds or conjugates of of Formulae I... |
|
Invention
|
Indazole derivatives as estrogen receptor degraders. Described herein are compounds of Formula I ... |
|
Invention
|
Tetrahydronaphthalene derivatives as estrogen receptor degraders. Described herein are compounds ... |
|
Invention
|
Indole derivatives as estrogen receptor degraders. Described herein are compounds of Formula I an... |
|
Invention
|
Chroman derivatives as estrogen receptor degraders. Described herein are compounds of Formula (I)... |
|
Invention
|
Tetrahydronaphthalene derivatives as estrogen receptor degraders |
|
Invention
|
Cereblon ligands and uses thereof. Described herein are compounds and conjugates of Formulae I an... |
|
Invention
|
Cereblon ligands and uses thereof. Described herein are compounds or conjugates of Formulae II an... |
|
Invention
|
Methods of identifying compounds for inducing protein-protein interaction.
The present disclosur... |
|
Invention
|
Ikzf2 degraders and uses thereof. Described herein are compounds of Formulae I' and their pharmac... |
|
Invention
|
Bicyclic heteroaryl-containing compounds as ikzf2 degraders.
Described herein are compounds of F... |
|
Invention
|
Ikzf2 degraders and uses thereof.
Described herein are compounds of Formulae I′ and their pharma... |
|
Invention
|
Cereblon ligands and uses thereof.
Described herein are compounds or conjugates of For... |
|
Invention
|
Cereblon ligands and uses thereof. e.ge.g., as cereblon-binding agents or bifunctional degraders ... |
|
Invention
|
Bicyclic heteroaryl-containing compounds as ikzf2 degraders. Described herein are compounds of Fo... |
|
G/S
|
Downloadable computer software for use in the field of drug discovery, screenings, and pharmaceut... |
|
G/S
|
Downloadable computer software for use in the field of drug
discovery, screenings, and pharmaceu... |
2022
|
G/S
|
Downloadable computer software for drug discovery, screenings, and providing pharmaceuticals; dow... |